Literature DB >> 6458494

Properties of three different molecular forms of the alpha 2 plasmin inhibitor.

I Clemmensen, S Thorsen, S Müllertz, L C Petersen.   

Abstract

Mesh:

Substances:

Year:  1981        PMID: 6458494     DOI: 10.1111/j.1432-1033.1981.tb05675.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


× No keyword cloud information.
  16 in total

1.  alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.

Authors:  C Kluft; H K Nieuwenhuis; D C Rijken; E Groeneveld; G Wijngaards; W van Berkel; G Dooijewaard; J J Sixma
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

2.  Roles for chloride ion and fibrinogen in the activation of [Glu1]plasminogen in human plasma.

Authors:  P J Gaffney; T Urano; V S de Serrano; M Mahmoud-Alexandroni; A R Metzger; F J Castellino
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

Review 3.  Aspects of C1-inhibitor biochemistry and pathophysiology.

Authors:  T K Nilsson
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

4.  Impact of the Pla protease substrate α2-antiplasmin on the progression of primary pneumonic plague.

Authors:  Justin L Eddy; Jay A Schroeder; Daniel L Zimbler; Lauren E Bellows; Wyndham W Lathem
Journal:  Infect Immun       Date:  2015-10-05       Impact factor: 3.441

5.  Different N-terminal forms of alpha 2-plasmin inhibitor in human plasma.

Authors:  K Bangert; A H Johnsen; U Christensen; S Thorsen
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

6.  Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.

Authors:  S Müllertz; S Thorsen; L Sottrup-Jensen
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

7.  Comparison of the behaviour in vivo of two molecular forms of antithrombin III.

Authors:  T H Carlson; A C Atencio; T L Simon
Journal:  Biochem J       Date:  1985-02-01       Impact factor: 3.857

8.  Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus.

Authors:  E J Dunn; H Philippou; R A S Ariëns; P J Grant
Journal:  Diabetologia       Date:  2006-03-16       Impact factor: 10.122

9.  Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.

Authors:  J M Edelberg; S V Pizzo
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

10.  Isolation of a fibronectin-binding protein from Staphylococcus aureus.

Authors:  F Espersen; I Clemmensen
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.